Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Integra LifeSciences Holdings Corporation (IART : NSDQ)
 
 • Company Description   
Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic products include devices and implants for foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. Surgeons don't have a minute to waste. They navigate a world of uncertainty while making thousands of decisions every day. These decisions directly affect patients - and surgeons.

Number of Employees: 3,800

 
 • Price / Volume Information   
Yesterday's Closing Price: $59.90 Daily Weekly Monthly
20 Day Moving Average: 495,146 shares
Shares Outstanding: 83.14 (millions)
Market Capitalization: $4,979.79 (millions)
Beta: 1.10
52 Week High: $76.70
52 Week Low: $55.18
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -6.27% 5.55%
12 Week -9.16% -0.14%
Year To Date -10.58% 8.83%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1100 CAMPUS ROAD
-
PRINCETON,NJ 08540
USA
ph: 609-275-0500
fax: 609-750-4277
michael.beaulieu@integralife.com http://www.integralife.com
 
 • General Corporate Information   
Officers
Jan De Witte - President and Chief Executive Officer
Stuart M. Essig - Chairman of the Board
Carrie L. Anderson - Executive Vice President and Chief Financial Offic
Jeffrey A. Mosebrook - Senior Vice President; Finance
Rhonda Germany Ballintyn - Director

Peer Information
Integra LifeSciences Holdings Corporation (ABMD)
Integra LifeSciences Holdings Corporation (DMDS)
Integra LifeSciences Holdings Corporation (CPWY.)
Integra LifeSciences Holdings Corporation (EQUR)
Integra LifeSciences Holdings Corporation (ECIA)
Integra LifeSciences Holdings Corporation (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 457985208
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/27/22
Share - Related Items
Shares Outstanding: 83.14
Most Recent Split Date: 1.00 (2.00:1)
Beta: 1.10
Market Capitalization: $4,979.79 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.80 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $3.31 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 9.60% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 18.10
Trailing 12 Months: 18.54
PEG Ratio: 1.89
Price Ratios
Price/Book: 3.08
Price/Cash Flow: 12.73
Price / Sales: 3.19
EPS Growth
vs. Year Ago Period: 7.25%
vs. Previous Quarter: -11.90%
Sales Growth
vs. Year Ago Period: 4.60%
vs. Previous Quarter: -7.12%
ROE
03/31/22 - 16.88
12/31/21 - 16.93
09/30/21 - 17.33
ROA
03/31/22 - 7.35
12/31/21 - 7.24
09/30/21 - 7.30
Current Ratio
03/31/22 - 3.38
12/31/21 - 3.39
09/30/21 - 3.32
Quick Ratio
03/31/22 - 2.34
12/31/21 - 2.46
09/30/21 - 2.33
Operating Margin
03/31/22 - 17.62
12/31/21 - 17.61
09/30/21 - 17.75
Net Margin
03/31/22 - 10.04
12/31/21 - 10.96
09/30/21 - 14.19
Pre-Tax Margin
03/31/22 - 11.98
12/31/21 - 13.92
09/30/21 - 13.23
Book Value
03/31/22 - 19.43
12/31/21 - 19.89
09/30/21 - 19.26
Inventory Turnover
03/31/22 - 1.83
12/31/21 - 1.84
09/30/21 - 1.83
Debt-to-Equity
03/31/22 - 0.93
12/31/21 - 0.89
09/30/21 - 0.92
Debt-to-Capital
03/31/22 - 48.18
12/31/21 - 47.12
09/30/21 - 47.88
 

Powered by Zacks Investment Research ©